The metabolic regulator Lamtor5 suppresses inflammatory signaling via regulating mTOR-mediated TLR4 degradation

Abstract

Comprehensive immune responses are essential for eliminating pathogens but must be tightly controlled to avoid sustained immune activation and potential tissue damage. The engagement of TLR4, a canonical pattern recognition receptor, has been proposed to trigger inflammatory responses with different magnitudes and durations depending on TLR4 cellular compartmentalization. In the present study, we identify an unexpected role of Lamtor5, a newly identified component of the amino acid-sensing machinery, in modulating TLR4 signaling and controlling inflammation. Specifically, Lamtor5 associated with TLR4 via their LZ/TIR domains and facilitated their colocalization at autolysosomes, preventing lysosomal tethering and the activation of mTORC1 upon LPS stimulation and thereby derepressing TFEB to promote autophagic degradation of TLR4. The loss of Lamtor5 was unable to trigger the TFEB-driven autolysosomal pathway and delay degradation of TLR4, leading to sustained inflammation and hence increased mortality among Lamtor5 haploinsufficient mice during endotoxic shock. Intriguingly, nutrient deprivation, particularly leucine deprivation, blunted inflammatory signaling and conferred protection to endotoxic mice. This effect, however, was largely abrogated upon Lamtor5 deletion. We thus propose a homeostatic function of Lamtor5 that couples pathogenic insults and nutrient availability to optimize the inflammatory response; this function may have implications for TLR4-associated inflammatory and metabolic disorders.

Identification of Differential Responses of Goat PBMCs to PPRV Virulence Using a Multi-Omics Approach

“…Some specific proteins also appeared at different stages of the infections. For example, after infection with MA08, these were proteins such as CNTRL involved in cell cycle progression and the late stages of cytokinesis, TNFAIP8L2, involved in the different stages of chronic viral infection, and LAMTOR5, are essential for the coordination of nutrient and inflammatory signals to shape optimised immune response ( 66 – 68 ). These proteins may play a role in the phenotype observed upon infection with this strain.…”

Role of TLR4/MyD88 Signaling Pathway in the Occurrence and Development of Uremia-Induced Myocardial Hypertrophy and Possible Mechanism

“…Endogenous ligands can activate TLR4. Activated TLR4 and related ligands induce NF-κB activation, initiating the transcription of interleukin-1, interleukin-6, interleukin-8, interleukin-12, tumor necrosis factor-α, and CD80 and CD86 genes and mediating the recognition and immune activation of various pathogens, resulting in kidney damage [17][18][19]. In the MyD88-dependent signaling pathway, after TLR4 recognizes and binds to the pathogen-associated molecular pattern (PAMP), it binds to MyD88 through its TIR region (Toll/IL-1 receptor domain) and activates the interleukin-1 receptor associated kinases (IRAK), tumor necrosis factor receptor associated factor 6 (TRAF6), complex membrane protein transforming growth factor related kinase 1 (TAK1), IκB kinase (IKK), and a series of proteases, which lead to the activation of NF-κB translocation to the nucleus and start tumor necrosis factor (TNF)-α and other inflammatory factors gene expression [20][21][22].…”

MicroRNA‑16 regulates lipopolysaccharide‑induced inflammatory factor expression by targeting TLR4 in normal human bronchial epithelial cells

“…TLR4 serves an essential role in the immne and inflammatory response ( 36 ). TLR4 is not only involved in acquired immunity, but also in innate immunity ( 37 ).…”